255 related articles for article (PubMed ID: 18555944)
1. Validity, reliability, and clinical importance of change in a 0-10 numeric rating scale measure of spasticity: a post hoc analysis of a randomized, double-blind, placebo-controlled trial.
Farrar JT; Troxel AB; Stott C; Duncombe P; Jensen MP
Clin Ther; 2008 May; 30(5):974-85. PubMed ID: 18555944
[TBL] [Abstract][Full Text] [Related]
2. A pilot study of a comparison between a patient scored numeric rating scale and clinician scored measures of spasticity in multiple sclerosis.
Anwar K; Barnes MP
NeuroRehabilitation; 2009; 24(4):333-40. PubMed ID: 19597271
[TBL] [Abstract][Full Text] [Related]
3. A double-blind, randomized, placebo-controlled, parallel-group study of Sativex, in subjects with symptoms of spasticity due to multiple sclerosis.
Collin C; Ehler E; Waberzinek G; Alsindi Z; Davies P; Powell K; Notcutt W; O'Leary C; Ratcliffe S; Nováková I; Zapletalova O; Piková J; Ambler Z
Neurol Res; 2010 Jun; 32(5):451-9. PubMed ID: 20307378
[TBL] [Abstract][Full Text] [Related]
4. Sativex(®) (tetrahydrocannabinol + cannabidiol), an endocannabinoid system modulator: basic features and main clinical data.
Vermersch P
Expert Rev Neurother; 2011 Apr; 11(4 Suppl):15-9. PubMed ID: 21449855
[TBL] [Abstract][Full Text] [Related]
5. Meta-analysis of the efficacy and safety of Sativex (nabiximols), on spasticity in people with multiple sclerosis.
Wade DT; Collin C; Stott C; Duncombe P
Mult Scler; 2010 Jun; 16(6):707-14. PubMed ID: 20558502
[TBL] [Abstract][Full Text] [Related]
6. A randomized, double-blind, placebo-controlled, parallel-group, enriched-design study of nabiximols* (Sativex(®) ), as add-on therapy, in subjects with refractory spasticity caused by multiple sclerosis.
Novotna A; Mares J; Ratcliffe S; Novakova I; Vachova M; Zapletalova O; Gasperini C; Pozzilli C; Cefaro L; Comi G; Rossi P; Ambler Z; Stelmasiak Z; Erdmann A; Montalban X; Klimek A; Davies P;
Eur J Neurol; 2011 Sep; 18(9):1122-31. PubMed ID: 21362108
[TBL] [Abstract][Full Text] [Related]
7. Correlation between spasticity and quality of life in patients with multiple sclerosis: the CANDLE study.
Arroyo R; Massana M; Vila C
Int J Neurosci; 2013 Dec; 123(12):850-8. PubMed ID: 23819835
[TBL] [Abstract][Full Text] [Related]
8. Development and validity testing of the neuropathy total symptom score-6: questionnaire for the study of sensory symptoms of diabetic peripheral neuropathy.
Bastyr EJ; Price KL; Bril V;
Clin Ther; 2005 Aug; 27(8):1278-94. PubMed ID: 16199253
[TBL] [Abstract][Full Text] [Related]
9. Psychometric properties of the Neck Disability Index and Numeric Pain Rating Scale in patients with mechanical neck pain.
Cleland JA; Childs JD; Whitman JM
Arch Phys Med Rehabil; 2008 Jan; 89(1):69-74. PubMed ID: 18164333
[TBL] [Abstract][Full Text] [Related]
10. Pathophysiology, assessment and management of multiple sclerosis spasticity: an update.
Haas J
Expert Rev Neurother; 2011 Apr; 11(4 Suppl):3-8. PubMed ID: 21449853
[TBL] [Abstract][Full Text] [Related]
11. The clinical importance of changes in the 0 to 10 numeric rating scale for worst, least, and average pain intensity: analyses of data from clinical trials of duloxetine in pain disorders.
Farrar JT; Pritchett YL; Robinson M; Prakash A; Chappell A
J Pain; 2010 Feb; 11(2):109-18. PubMed ID: 19665938
[TBL] [Abstract][Full Text] [Related]
12. Relationship between self- and clinically rated spasticity in spinal cord injury.
Lechner HE; Frotzler A; Eser P
Arch Phys Med Rehabil; 2006 Jan; 87(1):15-9. PubMed ID: 16401432
[TBL] [Abstract][Full Text] [Related]
13. Validation of the Serbian Version of Multiple Sclerosis Spasticity Scale 88 (MSSS-88).
Rodic SZ; Knezevic TI; Kisic-Tepavcevic DB; Dackovic JR; Dujmovic I; Pekmezovic TD; Drulovic JS; Konstantinovic LM
PLoS One; 2016; 11(1):e0147042. PubMed ID: 26771661
[TBL] [Abstract][Full Text] [Related]
14. Validity and reliability of the Serbian version of Patient-Reported Impact of Spasticity Measure in multiple sclerosis.
Knezevic T; Konstantinovic L; Rodic S; Foti C; Drulovic J; Dackovic J; Nikolic D; Petronic I; Stokic DS
Int J Rehabil Res; 2015 Sep; 38(3):199-205. PubMed ID: 25603541
[TBL] [Abstract][Full Text] [Related]
15. Psychometric properties of the Itch Numeric Rating Scale in patients with moderate-to-severe plaque psoriasis.
Kimball AB; Naegeli AN; Edson-Heredia E; Lin CY; Gaich C; Nikaï E; Wyrwich K; Yosipovitch G
Br J Dermatol; 2016 Jul; 175(1):157-62. PubMed ID: 26852717
[TBL] [Abstract][Full Text] [Related]
16. A randomized trial of memantine as treatment for spasticity in multiple sclerosis.
Mehta LR; McDermott MP; Goodman AD; Schwid SR
Mult Scler; 2010 Feb; 16(2):248-51. PubMed ID: 20028712
[TBL] [Abstract][Full Text] [Related]
17. Efficacy of nabiximols oromucosal spray on spasticity in people with multiple sclerosis: Treatment effects on Spasticity Numeric Rating Scale, muscle spasm count, and spastic muscle tone in two randomized clinical trials.
Nicholas J; Lublin F; Klineova S; Berwaerts J; Chinnapongse R; Checketts D; Javaid S; Steinerman JR
Mult Scler Relat Disord; 2023 Jul; 75():104745. PubMed ID: 37209500
[TBL] [Abstract][Full Text] [Related]
18. Measuring disease activity and functional status in patients with scleroderma and Raynaud's phenomenon.
Merkel PA; Herlyn K; Martin RW; Anderson JJ; Mayes MD; Bell P; Korn JH; Simms RW; Csuka ME; Medsger TA; Rothfield NF; Ellman MH; Collier DH; Weinstein A; Furst DE; Jiménez SA; White B; Seibold JR; Wigley FM;
Arthritis Rheum; 2002 Sep; 46(9):2410-20. PubMed ID: 12355489
[TBL] [Abstract][Full Text] [Related]
19. Advances in the management of multiple sclerosis symptoms: pathophysiology and assessment of spasticity in multiple sclerosis.
Tintoré M
Neurodegener Dis Manag; 2015; 5(6 Suppl):15-7. PubMed ID: 26611266
[TBL] [Abstract][Full Text] [Related]
20. Psychometric validation of the Psoriasis Symptom Diary using Phase III study data from patients with chronic plaque psoriasis.
Strober B; Zhao Y; Tran MH; Gnanasakthy A; Nyirady J; Papavassilis C; Nelson LM; McLeod LD; Mordin M; Gottlieb AB; Elewski BE; Lebwohl M
Int J Dermatol; 2016 Mar; 55(3):e147-55. PubMed ID: 26518255
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
